However, the non-specific production in response to PMA of pro-inflammatory TNF-α by CD3+ lymphocytes at admission was related to poor stroke outcomes at 90 days even after adjusting for baseline stroke severity (OR 1.13, 95% CI 1.01–1.27, p = 0.041). The gene discussed is TNF; the disease is stroke disorder.